Literature DB >> 10225856

Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit.

C Granert1, J Raud, A Waage, L Lindquist.   

Abstract

The inflammatory response in bacterial meningitis is mediated by cytokines, such as tumor necrosis factor alpha (TNF-alpha) and interleukin-1 (IL-1), which are produced in the subarachnoid space by different cells, e.g., leukocytes, astrocytes, and microglia. The recruitment of leukocytes into the cerebrospinal fluid (CSF) has been shown to contribute to the neurological damage in this disease, a process which could be enhanced by treatment with antibiotics. In this study, we have used a rabbit meningitis model for two sets of experiments with intracisternal (i.c.) injections of Streptococcus pneumoniae. First, pneumococcal cell wall (PCW) components were injected i.c., inducing an inflammatory response with pleocytosis and increased levels of CSF TNF-alpha) and IL-1 at 6 and 12 h after PCW injection. Treatment with fucoidin, known to inhibit leukocyte rolling, abolished pleocytosis and inhibited the release of TNF-alpha and IL-1. In the second experiment, live pneumococcal bacteria were injected i.c. and treatment with one dose of ampicillin (40 mg/kg of body weight intravenously) was given 16 h after induction of meningitis, causing a sevenfold increase in CSF leukocytes over a 4-h period. CSF IL-1 levels at 16 h were high but did not increase further at 20 h. Also, CSF TNF-alpha levels were high at 16 h and tended to increase at 20 h. Fucoidin treatment prevented the antibiotic-induced increase of CSF leukocytes but had no effect on the TNF-alpha and IL-1 levels. Taken together, fucoidin reduced CSF TNF-alpha and IL-1 levels in acute bacterial meningitis induced by PCW fragments but had no effect later in the course of the disease, when live bacteria were used and an inflammatory increase was caused by a dose of antibiotics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225856      PMCID: PMC115939     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

Review 1.  Leukocyte-endothelial adhesion molecules.

Authors:  T M Carlos; J M Harlan
Journal:  Blood       Date:  1994-10-01       Impact factor: 22.113

Review 2.  Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.

Authors:  A M van Furth; J J Roord; R van Furth
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

3.  The polysaccharide fucoidin inhibits the antibiotic-induced inflammatory cascade in experimental pneumococcal meningitis.

Authors:  C Granert; J Raud; L Lindquist
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis.

Authors:  E Tuomanen; B Hengstler; R Rich; M A Bray; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

5.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

6.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  Elimination of blood-derived macrophages inhibits the release of interleukin-1 and the entry of leukocytes into the cerebrospinal fluid in experimental pneumococcal meningitis.

Authors:  G Zysk; W Brück; I Huitinga; F R Fischer; F Flachsbarth; N van Rooijen; R Nau
Journal:  J Neuroimmunol       Date:  1997-03       Impact factor: 3.478

8.  A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo.

Authors:  K E Arfors; C Lundberg; L Lindbom; K Lundberg; P G Beatty; J M Harlan
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

9.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

10.  Mechanisms of brain injury in bacterial meningitis: workshop summary.

Authors:  H W Pfister; A Fontana; M G Täuber; A Tomasz; W M Scheld
Journal:  Clin Infect Dis       Date:  1994-09       Impact factor: 9.079

View more
  9 in total

1.  New Advances in the Pathogenesis and Pathophysiology of Bacterial Meningitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits.

Authors:  C Ostergaard; R V Yieng-Kow; T Benfield; N Frimodt-Møller; F Espersen; J D Lundgren
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

4.  Effect of doxycycline and meloxicam on cytokines, brain-derived neurotrophic factor, matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-3 and cyclooxygenase-2 in brain.

Authors:  Ayse Er; Devran Coskun; Emre Bahcivan; Burak Dik
Journal:  Iran J Basic Med Sci       Date:  2020-10       Impact factor: 2.699

5.  Fucoidin prevents Clostridium difficile toxin-A-induced ileal enteritis in mice.

Authors:  A R F Barreto; I C Cavalcante; M V Castro; A F T A Junqueira; M R Vale; R A Ribeiro; M H L P Souza; G A C Brito
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

6.  The responsiveness of TrkB to exogenous BDNF in frontal cortex during antibiotic treatment of Streptococcus pneumoniae meningitis.

Authors:  Xiaoqing Song; Di Lian; Dake He; Jiaming Sun; MingJie Zhu; Ling Li
Journal:  Neurol Sci       Date:  2014-07-11       Impact factor: 3.307

Review 7.  Fucoidans in Nanomedicine.

Authors:  Lucas Chollet; Pierre Saboural; Cédric Chauvierre; Jean-Noël Villemin; Didier Letourneur; Frédéric Chaubet
Journal:  Mar Drugs       Date:  2016-07-29       Impact factor: 5.118

Review 8.  Fucoidan as a marine anticancer agent in preclinical development.

Authors:  Jong-Young Kwak
Journal:  Mar Drugs       Date:  2014-01-28       Impact factor: 5.118

9.  Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis.

Authors:  Jingjing Li; Kan Chen; Sainan Li; Tong Liu; Fan Wang; Yujing Xia; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.